Thndr Claps
  • Egypt
  • Saudi
  • Thinkers
  • العربية
No Result
View All Result
Thndr Claps

Thndr Claps » U.S. Claps » Health & Pharma💉 » Talc-based baby powder pushed J&J against the wall 👶

Talc-based baby powder pushed J&J against the wall 👶

by Omar El Shorafa
August 15, 2022
J&J, NYSE, Claps

The Clap
Johnson & Johnson (NYSE: JNJ) will stop selling talc-based baby powder globally starting 2023.

The Deets
Two years ago, J&J suspended US sales of the product after the product led to numerous consumer safety concerns and legal issues. 

Many consumers filed lawsuits against J&J claiming that the talc-based baby powder caused cancer due to contamination. After denying these allegations, J&J announced the discontinuation of the product. 

How has this affected J&J?
The company has been facing costs of $3.5 billion in settlements to affected consumers. J&J assigned the claims to its subsidiary LTL Management, which then filed for bankruptcy, which paused any pending lawsuits.

Now, the company will discontinue the sale of the product, putting into question whether J&J knew about the side effects or not.

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)

Related Posts

Claps, Health
Health & Pharma 💉

Moderna signs deal with China 🤝

by Omar El Shorafa
July 6, 2023
Claps, Health & Pharma
Health & Pharma 💉

Pfizer looking to fund Seagen acquisition 💰

by Omar El Shorafa
May 18, 2023
Claps, Health & Pharma
Health & Pharma 💉

Pharmaceutical companies to go to war against Medicare 💊

by Omar El Shorafa
May 12, 2023
Aveeno, Neutrogena, Johnson’s, Tylenol and Dr.Ci:Labo feature in the Kenvue portfolio
Health & Pharma 💉

Kenvue to focus on brand & product innovation 👀

by Omar El Shorafa
May 8, 2023
Claps, Health & Pharma
Health & Pharma 💉

Moderna flying high in Q1 💉

by Omar El Shorafa
May 4, 2023
Claps, Health & Pharma
Health & Pharma 💉

Pfizer unfazed by Covid vaccine sales decline 💉

by Omar El Shorafa
May 3, 2023

Website

Community

Blog

Learn

© Thndr. All rights reserved

No Result
View All Result
  • Egypt
  • Saudi
  • Thinkers
  • العربية

Disclaimer: Thndr does not provide investment advice, individual investors are responsible for their own decisions or can seek independent advice. The value of investments can go up and down. Thndr is a trading name of Thndr Securities Brokerage which is authorised and regulated by the Financial Regulatory Authority (FRA). Registered in Egypt (no. 804)..© Thndr. All rights reserved

 

Hello👋 We want you to be able to express your opinions on anything and everything finance and economics related to the Egyptian and US markets.

This is why we introduced Thndr Thinkers💭

Let’s go through some housekeeping notes before you jump into publishing your article to all Thndr Claps readers!

Type of Content📝 We want to see market-relevant content that shows good analysis, please! Base your articles on facts 

Don’t be shy, explain🗣 Flex your knowledge to us, and we’ll share it with all the readers!

Be Original🙏 Please don’t copy. No one likes a copycat. All submissions are welcome as long as they’re yours 

Make your title attractive🤩 A title is like the cover of your book. Attractive enough to make you look at the book but also clear enough to tell you what the book is about.

Clean🧹 We’re all humans and we all make mistakes. But please try and clean up the article so it’s clear for all the readers 

No promotional content🚫 We don’t publish promotional content.

Any questions about becoming a Thndr Thinker? Email thndrclaps@thndr.app and we’d be happy to help!

Normally, your article will be published within 24 hours of submission (if you followed the guidelines)